Precision for Medicine Gets $150M to Support Growth
April 09, 2013
Precision for Medicine has secured $150 million in private equity financing from Oak Investment Partners, J.H. Whitney & Co. and its co-founders to support acquisitions and development. Headquartered in Chevy Chase, MD and formed in 2012, Precision is building a platform of specialized development and commercialization services to help life science companies capitalize on the emerging "precision medicine" space. The funding will be used to acquire the expertise and infrastructure necessary to guide medical products from discovery to patients.